UGIF
WX

US Global Investors Funds’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

US Global Investors Funds’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$546K Buy
+14,239
New +$450K 0.1% 168

Other funds holding WX

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $31.2B AUM 40.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

US Global Investors Funds's WX Position: Q4 2013 in Review

US Global Investors Funds opened a new position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2013: 14,239 shares worth $546K. The stake represents 0.1% of the portfolio and ranks #168 among its holdings.

164 funds tracked by Wall St. Rank hold WX as of Q4 2013.

  • US Global Investors Funds held 14,239 shares of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS worth $546K as of Q4 2013.
  • WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS was a new US Global Investors Funds position in Q4 2013.
  • WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS made up 0.1% of US Global Investors Funds's portfolio in Q4 2013, its #168 holding.
  • 164 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2013.

Based on US Global Investors Funds's 13F filing for Q4 2013, filed 18 Feb 2014.